Daily Longitudinal Sampling of SARS-CoV-2 Infection Reveals Substantial Heterogeneity in Infectiousness

The dynamics of SARS-CoV-2 replication and shedding in humans remain poorly understood. We captured the dynamics of infectious virus and viral RNA shedding during acute infection through daily longitudinal sampling of 60 individuals for up to 14 days. By fitting mechanistic models, we directly estimated viral expansion and clearance rates and overall infectiousness for each individual. Significant person-to-person variation in infectious virus shedding suggests that individual-level heterogeneity in viral dynamics contributes to 'superspreading'. Viral genome loads often peaked days earlier in saliva than in nasal swabs, indicating strong tissue compartmentalization and suggesting that saliva may serve as a superior sampling site for early detection of infection. Viral loads and clearance kinetics of Alpha (B.1.1.7) and previously circulating non-variant-of-concern viruses were mostly indistinguishable, indicating that the enhanced transmissibility of this variant cannot be explained simply by higher viral loads or delayed clearance. These results provide a high-resolution portrait of SARS-CoV-2 infection dynamics and implicate individual-level heterogeneity in infectiousness in superspreading.

Citing Articles

Estimating Mean Viral Load Trajectory From Intermittent Longitudinal Data and Unknown Time Origins.

Woodbridge Y, Mandel M, Goldberg Y, Huppert A Stat Med. 2025; 44(5):e70033.

PMID: 39995297 PMC: 11851093. DOI: 10.1002/sim.70033.

The ratio between SARS-CoV-2 RNA viral load and culturable viral titre differs depending on the stage of infection: a case study of household transmission in an adult male.

Porter M, Viloria Winnett A, Hao L, Shelby N, Reyes J, Schlenker N Access Microbiol. 2025; 7(2).

PMID: 39967741 PMC: 11833051. DOI: 10.1099/acmi.0.000732.v3.

Within-host genetic diversity of SARS-CoV-2 across animal species.

Naderi S, Sagan S, Shapiro B Virus Evol. 2025; 11(1):veae117.

PMID: 39830312 PMC: 11739616. DOI: 10.1093/ve/veae117.

Defining the Critical Requisites for Accurate Simulation of SARS-CoV-2 Viral Dynamics: Patient Characteristics and Data Collection Protocol.

Chua H, Singh A, Wang Y, Goh Y, Chan C, Chavatte J J Med Virol. 2025; 97(1):e70174.

PMID: 39817600 PMC: 11736999. DOI: 10.1002/jmv.70174.

A modeling study to define guidelines for antigen screening in schools and workplaces to mitigate COVID-19 outbreaks.

Jeong Y, Ejima K, Kim K, Iwanami S, Hart W, Thompson R Commun Med (Lond). 2025; 5(1):2.

PMID: 39753869 PMC: 11699287. DOI: 10.1038/s43856-024-00716-3.

References

He X, Lau E, Wu P, Deng X, Wang J, Hao X . Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020; 26(5):672-675. DOI: 10.1038/s41591-020-0869-5. View

Szablewski C, Chang K, Brown M, Chu V, Yousaf A, Anyalechi N . SARS-CoV-2 Transmission and Infection Among Attendees of an Overnight Camp - Georgia, June 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(31):1023-1025. PMC: 7454898. DOI: 10.15585/mmwr.mm6931e1. View

Long Q, Tang X, Shi Q, Li Q, Deng H, Yuan J . Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020; 26(8):1200-1204. DOI: 10.1038/s41591-020-0965-6. View

Li R, Pei S, Chen B, Song Y, Zhang T, Yang W . Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020; 368(6490):489-493. PMC: 7164387. DOI: 10.1126/science.abb3221. View

Sun K, Wang W, Gao L, Wang Y, Luo K, Ren L . Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2. Science. 2020; 371(6526). PMC: 7857413. DOI: 10.1126/science.abe2424. View

Adam D, Wu P, Wong J, Lau E, Tsang T, Cauchemez S . Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nat Med. 2020; 26(11):1714-1719. DOI: 10.1038/s41591-020-1092-0. View

Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z . Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020; 20(8):911-919. PMC: 7185944. DOI: 10.1016/S1473-3099(20)30287-5. View

Lloyd-Smith J, Schreiber S, Kopp P, Getz W . Superspreading and the effect of individual variation on disease emergence. Nature. 2005; 438(7066):355-9. PMC: 7094981. DOI: 10.1038/nature04153. View

Neant N, Lingas G, Le Hingrat Q, Ghosn J, Engelmann I, Lepiller Q . Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort. Proc Natl Acad Sci U S A. 2021; 118(8). PMC: 7929555. DOI: 10.1073/pnas.2017962118. View

10.

Larremore D, Wilder B, Lester E, Shehata S, Burke J, Hay J . Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening. Sci Adv. 2020; 7(1). PMC: 7775777. DOI: 10.1126/sciadv.abd5393. View

11.

Kim J, Ko J, Kim Y, Kim Y, Kim J, Chung Y . Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea. J Korean Med Sci. 2020; 35(7):e86. PMC: 7036338. DOI: 10.3346/jkms.2020.35.e86. View

12.

Wolfel R, Corman V, Guggemos W, Seilmaier M, Zange S, Muller M . Virological assessment of hospitalized patients with COVID-2019. Nature. 2020; 581(7809):465-469. DOI: 10.1038/s41586-020-2196-x. View

13.

Lescure F, Bouadma L, Nguyen D, Parisey M, Wicky P, Behillil S . Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020; 20(6):697-706. PMC: 7156120. DOI: 10.1016/S1473-3099(20)30200-0. View

14.

Young B, Ong S, Kalimuddin S, Low J, Tan S, Loh J . Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. JAMA. 2020; 323(15):1488-1494. PMC: 7054855. DOI: 10.1001/jama.2020.3204. View

15.

Kissler S, Fauver J, Mack C, Olesen S, Tai C, Shiue K . Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies. PLoS Biol. 2021; 19(7):e3001333. PMC: 8297933. DOI: 10.1371/journal.pbio.3001333. View

16.

Shain E, Clemens J . A new method for robust quantitative and qualitative analysis of real-time PCR. Nucleic Acids Res. 2008; 36(14):e91. PMC: 2504305. DOI: 10.1093/nar/gkn408. View

17.

Ke R, Zitzmann C, Ho D, Ribeiro R, Perelson A . In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness. Proc Natl Acad Sci U S A. 2021; 118(49). PMC: 8670484. DOI: 10.1073/pnas.2111477118. View

18.

Pawelek K, Huynh G, Quinlivan M, Cullinane A, Rong L, Perelson A . Modeling within-host dynamics of influenza virus infection including immune responses. PLoS Comput Biol. 2012; 8(6):e1002588. PMC: 3386161. DOI: 10.1371/journal.pcbi.1002588. View

19.

Goyal A, Cardozo-Ojeda E, Schiffer J . Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response. Sci Adv. 2020; 6(47). PMC: 7679107. DOI: 10.1126/sciadv.abc7112. View

20.

Blanco-Melo D, Nilsson-Payant B, Liu W, Uhl S, Hoagland D, Moller R . Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell. 2020; 181(5):1036-1045.e9. PMC: 7227586. DOI: 10.1016/j.cell.2020.04.026. View